Dale Porter Selected Research

Dale Porter Research Topics

Disease

13	Neoplasms (Cancer) 12/2021 - 03/2003
5	Carcinogenesis 02/2015 - 01/2002
5	Breast Neoplasms (Breast Cancer) 02/2015 - 01/2002
2	Hyperphosphatemia 01/2018 - 01/2017
2	Melanoma (Melanoma, Malignant) 01/2017 - 03/2013
1	Cholangiocarcinoma 01/2018
1	Constipation 01/2018
1	Fatigue 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2005
1	Lung Neoplasms (Lung Cancer) 08/2004
1	Myoepithelioma 07/2004
1	Silicosis 05/2002
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2002
1	Inflammation (Inflammations) 05/2002
1	Granuloma 05/2002
1	Fibrosis (Cirrhosis) 05/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2004
3	infigratinibIBA 01/2018 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2017
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018 - 01/2017
2	dicarboxydine (DCD)IBA 02/2015 - 09/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2010 - 05/2002
2	Estrogen ReceptorsIBA 08/2002 - 01/2002
1	human PRMT2 proteinIBA 01/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2018
1	CreatinineIBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2017
1	InterferonsIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017
1	Toll-Like Receptor 3IBA 01/2017
1	Drug CombinationsIBA 12/2016
1	Small Interfering RNA (siRNA)IBA 02/2015
1	dermcidinIBA 02/2015
1	Phenobarbital (Luminal)FDA Link 02/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2013
1	Molecular Chaperones (Chaperone, Molecular)IBA 06/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2013
1	obatoclaxIBA 03/2013
1	Inhibitor of Apoptosis ProteinsIBA 09/2010
1	CytochromesIBA 08/2004
1	DNA (Deoxyribonucleic Acid)IBA 08/2004
1	Coal (Coals)IBA 08/2004
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 08/2004
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 08/2004
1	SmokeIBA 08/2004
1	ChemokinesIBA 07/2004
1	Messenger RNA (mRNA)IBA 03/2003
1	Lipocalin-2IBA 08/2002
1	UteroglobinIBA 06/2002
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2002
1	Silicon Dioxide (Silica)FDA LinkGeneric 05/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2002
1	CytokinesIBA 05/2002
1	NF-kappa B (NF-kB)IBA 05/2002
1	Oxidants (Oxidizing Agents)IBA 05/2002
1	Interleukin-1 (Interleukin 1)IBA 05/2002
1	Explosive Agents (Explosives)IBA 05/2002
1	Tamoxifen FDA LinkGeneric 01/2002
1	LigandsIBA 01/2002
1	Transcription Factors (Transcription Factor)IBA 01/2002
1	Estrogens (Estrogen)FDA Link 01/2002

Therapy/Procedure

4	Therapeutics 01/2018 - 09/2010
2	Drug Therapy (Chemotherapy) 01/2018 - 12/2016
1	Precision Medicine 06/2021